APA (7th ed.) Citation

CH, M., D, F., M, C., MJ, C., WA, F., N, G., . . . RP, M. (2018). Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin αvβ6 inhibitor, in healthy participants. European journal of clinical pharmacology, 74(6), 701. https://doi.org/10.1007/s00228-018-2435-3

Chicago Style (17th ed.) Citation

CH, Maden, et al. "Safety, Tolerability and Pharmacokinetics of GSK3008348, a Novel Integrin αvβ6 Inhibitor, in Healthy Participants." European Journal of Clinical Pharmacology 74, no. 6 (2018): 701. https://doi.org/10.1007/s00228-018-2435-3.

MLA (9th ed.) Citation

CH, Maden, et al. "Safety, Tolerability and Pharmacokinetics of GSK3008348, a Novel Integrin αvβ6 Inhibitor, in Healthy Participants." European Journal of Clinical Pharmacology, vol. 74, no. 6, 2018, p. 701, https://doi.org/10.1007/s00228-018-2435-3.